Forbius
Blood & Organ Banks · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
750 Boul. Saint-laurent Ste 101, Montrea...Phone Number
(512) 614-4199Website
www.forbius.comRevenue
$6.7 MillionIndustry
About Forbius
Forbius Org Chart
Remote Clinical Research Coordinator
DE Contedo Web Editor
Is Forbius your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Forbius
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Forbius recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Forbius had a recent Job posting/layoffs
Forbius, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Forbius is spiking on competitors!
Product Launch: Get notified when Forbius launches new products
Check if Forbius has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Forbius has new funding data
Recommended Actions
Reach out to Masked Content who joined Forbius as Masked Content
Find 3 more new buyers
Compare Similar Companies to Forbius
Compare insights from companies similar to Forbius, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Forbius is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Forbius is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Forbius.
Forbius Tech Stack
A closer look at the technologies used by Forbius
Most Recent Scoops
Forbius News & Media
Forbius to Present at Jefferies 2019 London Healthcare Conference
AUSTIN, Texas & MONTREAL--(BUSINESS WIRE)-- #Austin--Forbius to Present at Jefferies 2019 London Healthcare ConferenceForbius Completes Phase 1 Oncology Dose-Escalation with AVID200, First-in-Class TGF-beta 1 & 3 Inhibitor: Well Tolerated, Target Inhibition Demonstrated at All Dose Levels, Data Reported at SITC
AUSTIN, Texas & MONTREAL--(BUSINESS WIRE)-- #AVID200--AVID200 well tolerated, no DLTs, SAEs or adverse events greater than Grade 2 observed at highest tested dose level. Reported at SITC 2019.SITC 2019: Forbius to Report Phase 1a Oncology Clinical Data with AVID200, First-in-Class TGF-beta 1 & 3 Inhibitor, in Late-Breaking Poster Presentation
AUSTIN, Texas & MONTREAL--(BUSINESS WIRE)-- #Austin--First report of oncology data with selective TGF-beta inhibitor AVID200: well tolerated, target engagement over entire dosing period, MTD not reached.Forbius Completes Enrollment into Phase 1a Solid Tumor Trial of AVID200, First-in-Class TGF-beta 1 & 3 Inhibitor; Closes Series C Financing
AUSTIN, Texas & MONTREAL--(BUSINESS WIRE)--Forbius Announces AVID200-03 Phase 1 Oncology Trial Enrollment Complete; Closes Series C Financing
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Forbius
Forbius is a clinical-stage protein engineering company that develops biotherapeutics to treat fibrosis and cancer. Their headquarters is in Montreal, Quebec, Canada.... Read More